Cost-Benefit Analysis

"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.

Descriptor ID	D003362
MeSH Number(s)	N03.219.151.125
Concept/Terms	Cost-Benefit Analysis Cost-Benefit Analysis Analyses, Cost-Benefit Analysis, Cost-Benefit Cost-Benefit Analyses Cost Benefit Analysis Analyses, Cost Benefit Analysis, Cost Benefit Cost Benefit Analyses Cost Effectiveness Cost Effectiveness Effectiveness, Cost Cost-Benefit Data Cost-Benefit Data Cost Benefit Data Data, Cost-Benefit Cost-Utility Analysis Cost-Utility Analysis Analyses, Cost-Utility Analysis, Cost-Utility Cost Utility Analysis Cost-Utility Analyses Economic Evaluation Economic Evaluation Economic Evaluations Evaluation, Economic Evaluations, Economic Marginal Analysis Marginal Analysis Analyses, Marginal Analysis, Marginal Marginal Analyses Cost Benefit Cost Benefit Costs and Benefits Benefits and Costs Cost-Effectiveness Analysis Cost-Effectiveness Analysis Analysis, Cost-Effectiveness Cost Effectiveness Analysis

Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".

Health Care [N]
Health Care Economics and Organizations [N03]
Economics [N03.219]
Costs and Cost Analysis [N03.219.151]
Cost-Benefit Analysis [N03.219.151.125]

Below are MeSH descriptors whose meaning is related to "Cost-Benefit Analysis".

Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.

Bar chart showing 248 publications over 27 distinct years, with a maximum of 26 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1998	0	3	3
2000	0	3	3
2001	0	3	3
2002	0	5	5
2003	0	9	9
2004	1	4	5
2005	1	7	8
2006	2	5	7
2007	0	6	6
2008	1	6	7
2009	0	9	9
2010	0	9	9
2011	0	9	9
2012	0	10	10
2013	0	8	8
2014	5	21	26
2015	3	14	17
2016	9	14	23
2017	5	14	19
2018	1	9	10
2019	2	8	10
2020	1	14	15
2021	2	7	9
2022	0	7	7
2023	1	5	6
2024	2	2	4

Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.

Rando H, Musoni M, Greenwood BC, Ingabire L, Van Hook S, Bolman CP, Bolman RM, Lin Y. The path to sustainable cardiac surgery in Rwanda: analysis of costs for consumables used during cardiac surgery for a non-governmental organization. J Cardiothorac Surg. 2024 Oct 01; 19(1):574.

View in: PubMed
Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP. Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts. JAMA Netw Open. 2024 Oct 01; 7(10):e2437233.

View in: PubMed
Hansen DK, Lu X, Puglianini OC, Sorensen S, Usmani SZ, Zhang E, Huo S, Zhang Y, Qureshi ZP, Jagannath S. Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4. Front Immunol. 2024; 15:1408892.

View in: PubMed
Aaron SD, Montes de Oca M, Celli B, Bhatt SP, Bourbeau J, Criner GJ, DeMeo DL, Halpin DMG, Han MK, Hurst JR, Krishnan JK, Mannino D, van Boven JFM, Vogelmeier CF, Wedzicha JA, Yawn BP, Martinez FJ. Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding. Am J Respir Crit Care Med. 2024 04 15; 209(8):928-937.

View in: PubMed
O'Callaghan L, Chertavian E, Johnson SJ, Ferries E, Deligiannidis KM. The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States. J Med Econ. 2024 Jan-Dec; 27(1):492-505.

View in: PubMed
Jacob V, Reynolds JA, Chattopadhyay SK, Hopkins DP, Brown DR, Devlin HM, Barrett A, Berrigan D, Crespo CJ, Heath GW, Brownson RC, Cuellar AE, Clymer JM, Chriqui JF. Parks, Trails, and Greenways for Physical Activity: A Community Guide Systematic Economic Review. Am J Prev Med. 2024 06; 66(6):1089-1099.

View in: PubMed
De Goeij FHC, De Meijer V, Mergental H, Guarrera JV, Asthana S, Ghinolfi D, Boteon YL, Selzner N, Kalisvaart M, Pulitano C, Sonnenday C, Martins PN, Berlakovich G, Schlegel A. Challenges With the Implementation of Machine Perfusion in Clinical Liver Transplantation. Transplantation. 2024 Jun 01; 108(6):1296-1307.

View in: PubMed
Reynolds MR, Stein AB, Sun X, Hytopoulos E, Steinhubl SR, Cohen DJ. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circ Cardiovasc Qual Outcomes. 2023 11; 16(11):e009751.

View in: PubMed
Flam-Ross JM, Marsh E, Weitz M, Savinkina A, Schackman BR, Wang J, Madushani RWMA, Morgan JR, Barocas JA, Walley AY, Chrysanthopoulou SA, Linas BP, Assoumou SA. Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder. JAMA Netw Open. 2023 09 05; 6(9):e2329583.

View in: PubMed
Wang L, Lauren BN, Hager K, Zhang FF, Wong JB, Kim DD, Mozaffarian D. Health and Economic Impacts of Implementing Produce Prescription Programs for Diabetes in the United States: A Microsimulation Study. J Am Heart Assoc. 2023 08; 12(15):e029215.

View in: PubMed

People

Explore

Similar Concepts

Top Journals